FX.co ★ Gilead Sciences Chief Medical Officer Merdad Parsey To Resign

Gilead Sciences, Inc. (GILD) announced on Wednesday that Merdad Parsey will step down from his role as Chief Medical Officer early next year. The company has begun the search for a successor, and Parsey will continue to serve in his current capacity until the first quarter of 2025. As of now, Gilead Sciences' stock is trading at $73.06, an increase of 1.98 percent on the Nasdaq.